Viewing nowIl-Yang Bio Atorvastatin Calcium Hemihydrate Tablet 20 Milligrams
Atorvastatin Calcium Hydrate 21.69mg
Tablet · Prescription medication
Il-Yang Biopharm Co., Ltd.

MFDS item code 201400190 · Approved 2014.01.16 · Insurance code 696600980
Improvement of hyperlipidemia (including pediatric familial hyperlipidemia), prevention of cardiovascular disease
This medication helps reduce the risk of various cardiovascular diseases. It lowers the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease and patients with type 2 diabetes, and also reduces the risk of revascularization and angina. Additionally, it decreases the risk of myocardial infarction, stroke, congestive heart failure hospitalization, and angina in patients who already have coronary heart disease. In patients with hyperlipidemia, it lowers total cholesterol and LDL cholesterol and raises HDL cholesterol, thus aiding therapeutic effects. This medication is used as an adjunct to diet in patients with hypercholesterolemia and particularly contributes to the treatment of familial hypercholesterolemia in pediatric patients. Overall, it is used to improve cardiovascular health and effectively manage hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (40 mg is only for patients requiring an LDL cholesterol reduction of 45 % or more). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. As the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this drug higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle-related side effects. If severe muscle pain or weakness occurs, or if there is a significant increase in creatine kinase levels, immediately discontinue use and consult a doctor. There is a risk of serious muscle diseases such as myopathy or rhabdomyolysis, so patients with specific infections, surgeries, trauma, or metabolic disorders need to exercise caution. Patients with liver function problems or liver disease should not use this medication, and regular liver function tests should be performed; if abnormalities arise, discontinue use. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication, and women of childbearing age should use appropriate contraception during treatment. Children under 10 years old and patients with specific epilepsy or muscle disorders should also not use this medication. Alcoholics or patients with a history of liver disease should use this medication with caution, and elderly patients are also at higher risk for myopathy. This medication may interact with various drugs, so anyone taking other medications should inform their doctor or pharmacist, especially when taking certain antibiotics, antifungals, HIV medications, some antihypertensives, antidiabetics, oral contraceptives, etc. Various side effects may occur, including muscle pain, fatigue, dyspepsia, headache, insomnia, and skin rash; if symptoms persist or are severe, immediate consultation with healthcare providers is advised. There is no specific antidote for overdose, so one should go to the hospital immediately for symptomatic treatment and monitor liver function and muscle condition. This medication should be stored out of the reach of children and kept in its original container for safety. If symptoms such as muscle pain or weakness, fever, or fatigue occur during treatment, inform a doctor immediately, and it is important to regularly check liver and muscle status.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is best to store it at room temperature between 1 to 30 degrees Celsius. This method helps maintain the medication's efficacy and prevent degradation.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.69mg
Tablet · Prescription medication
Il-Yang Biopharm Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.